MD · MBA
Founder & CEO, Sequencing.com
Founder of Sequencing and author of Outsmart Your Genes. An early voice in direct-to-consumer genetic testing.
Brandon Colby is a physician-expert in the fields of Genetic Analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University`s Graduate School of Business, and a BA with Honors in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Dr. Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Explore how genetic testing aids in diagnosing Acute Leukemia of Ambiguous Lineage by identifying mutations, guiding treatment plans, and improving patient outcomes.
Explore how genetic testing is revolutionizing pediatric acute liver failure diagnosis and treatment, highlighting whole-exome sequencing's role and future implications.
Genetic testing enhances precision in diagnosing acute megakaryoblastic leukemia, aids personalized treatment, and develops targeted therapies, revolutionizing patient care.
Explore the impact of genetic testing on Acute Myeloid Leukemia. Understand GFI1-36N SNP's role in diagnosis, personalized treatment, and monitoring in AML.
Explore how genetic testing revolutionizes AML with Multilineage Dysplasia diagnosis, prognosis, and personalized treatment for improved patient outcomes.
Explore how genetic testing plays a crucial role in diagnosing and managing Alpha-N-acetylgalactosaminidase Deficiency Type 3, a rare lysosomal disorder.
Explore how genetic testing revolutionizes Alport syndrome diagnosis, enabling early detection, personalized treatment, and informed family planning decisions.
Explore how genetic testing enhances the diagnosis and management of amelogenesis imperfecta, a hereditary enamel disorder, ensuring personalized dental care.